COLL vs DAL
Collegium Pharmaceutical Inc (COLL) versus Delta Air Lines Inc (DAL) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Not investment advice. Open the COLL and DAL stock pages for the full models.
Not investment advice.